Cargando…
Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history
Two-dose messenger RNA vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective in preventing symptomatic COVID-19 infection. However, the durability of protection is not known, nor is the effectiveness against emerging viral variants. Additionally, vacc...
Autores principales: | McDade, Thomas W., Demonbreun, Alexis R., Sancilio, Amelia, Mustanski, Brian, D’Aquila, Richard T., McNally, Elizabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405730/ https://www.ncbi.nlm.nih.gov/pubmed/34462501 http://dx.doi.org/10.1038/s41598-021-96879-3 |
Ejemplares similares
-
A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples
por: Sancilio, Amelia E., et al.
Publicado: (2021) -
Low Levels of Neutralizing Antibodies After Natural Infection With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community-Based Serological Study
por: McDade, Thomas W, et al.
Publicado: (2022) -
Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals.
por: Demonbreun, Alexis R., et al.
Publicado: (2021) -
COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study
por: Sancilio, Amelia, et al.
Publicado: (2022) -
COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to Men
por: Demonbreun, Alexis R, et al.
Publicado: (2021)